HKEX: 950
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
View original source (HKEXnews)
Earlier from Lee's Pharmaceutical
- Lee Pharmaceutical: Connected Transaction - Provision of Financial Assistance
- Lee Pharmaceutical: Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed from Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China
- Lee's Pharmaceutical Holdings Limited: - Grant of Share Options
- Lee's Pharmaceutical Holdings Limited: - Establishment of the Group Commercial Operations Centre